georgie18's House of Gain...

[Penny Machine]

BYSD .0003 buys picking up momentum, next CCTL type bitcoin runner?

[georgie18]

CCTL...0004...entered again...after the overbought retrace....

[nvidiaforgames]

ASKH another poster spoke to CEO last night confirmed merger closing anyday now

[georgie18]

STEV...0022...high of the day...

[Traderfan]

Bid is waking up. Aquisition announcement overdue here. Let's hope something is coming soon.

[TheLionAndTheLamb]

Took some MLHC 0.0002. Bid activity there.

[georgie18]

FTEG...0012...adding what they give me...

[georgie18]

DCTH...059...

[georgie18]

Must Read... BYSD....

gwylm  
Thursday, 12/07/17 11:17:24 AM
Re: None

Post # of 65835 


BYSD is in the business of securing bitcoins and preventing exactly what happened this week at NiceHash.com (one of the top 3 largest mining pools in the world). I'm surprised nobody is talking about this. This immediately shows that BYSD's business and business model is necessary and growing!

Read the news! http://money.cnn.com/2017/12/07/technology/nicehash-bitcoin-theft-hacking/index.html

[georgie18]

Lets call it $25,000 by December 22....

[Penny Machine]

HAON 25m block .0002

[georgie18]

DCTH...0539...3 Million o/s post split...

[Penny Machine]

Update: shortly after blowing past $16,000, bitcoin has risen above $17,000 on coinbase exchange

UPDATE: Shortly after blowing past $16,000, Bitcoin has risen above $17,000 on Coinbase exchange https://t.co/Sy3VDBX3SI

— CNBC Now (@CNBCnow) December 7, 2017

[Penny Machine]

CNXS 40m block

[Rainer]

SHMN .0009 buyers returning, bitcoin news / update coming per last pr

[georgie18]

I have no tactics...I observe and serve the charts...your quite welcome...

[Apok]

Starting to pick up on some of your tactics... thanks for the help

[georgie18]

My range as well...

[georgie18]

RMRK...0008...

[georgie18]

DCTH...0519...in on the dip...

[Apok]

Following suit... looking around that 200 SMA for re-entry, what do you think?

[MIKEY501]

$16,300 right now

[Penny Machine]

Goodness its looking like bitcoin could break $16,000 Today! CNXS, FWDG, TONR & MRNJ

[georgie18]

RMRK...0007 Symmetrical Triangle breakout...watch for Psar to flip to a bullish buy position and out of the trips we go...imo...we shall see...

[georgie18]

MCIG....2265...High of the day...

[georgie18]

SVTE...pulled my order way too much selling here...will wait to see if she settles...

[georgie18]

SVTE...0002 bidding the dip...

[jeff66]

STSC running again

[georgie18]

UAMM...yup...

[georgie18]

Thanks always good to have a little why to buy....

[georgie18]

PURA...all out...overbought and trading way outside the upper bollie...watching to enter again...

[jokerwild477]

Close to a million smackers in 30 minutes trading volume.. Ain't IH

[gwat1979]

UAMM .0105 with .011 on the ask. vndm is a scarecrow there imo. OS hasn't changed here in a very long time.

[ANTI-BAGHOLDER]

WOFA 5's up

[jokerwild477]

Prepac bankr.. The terms of it.... DD on yahoo message board.... JOKER

[gwat1979]

VDRM .0175

[georgie18]

Why...

[georgie18]

MCIG...22...

[Penny Machine]

Correction SVTE ran to .0007 yesterday

[jokerwild477]

WAC.... Keep both eyes on this one... 68x....69....??

[Penny Machine]

SVTE ran straight to .0006 yesterday, .0003 cheap?

[georgie18]

PURA...044...

[georgie18]

Thanks...PURA...Sweet move...

[gwat1979]

PURA nice georgie! I'm holding there...

[gwat1979]

VDRM here's the news:

ViaDerma, Inc. Looks to have Sales Representatives Selling its FDA Registered Medication VitaStem to a Network of 1000 Physician Offices Nationwide in 2018

LOS ANGELES, CA--(Marketwired - December 07, 2017) - ViaDerma, Inc. (OTC PINK: VDRM), a specialty pharmaceutical company devoted to bringing new products to market, recently announced today that the Company has begun sales and distribution of its highly anticipated topical antibiotic ointment Vitastem. ViaDerma will work with a new sales and marketing group to put 25 sales representatives on the ground selling ViaDerma's products to networks of Hospitals and directly to physicians' offices. The projected revenues for 2018 from this initiative should generate $6.9 million dollars.

The Company has a new distributor in the Philippines, whereby ViaDerma and Biogenx have agreed in principle to terms to distribute VitaStem in the Philippines. The Agreement calls for purchase minimums of 42,500 units the first year, 75,000 the 2nd year, and 125,000 units the 3rd year. The Company expects to ramp up production, monthly as interest in the product continues to grow. ViaDerma estimates they could ramp up production to 75,000 units per month over the next few years.

ViaDerma also believes sales in Japan will start soon with an initial demand for approximately 10,000 units of VitaStem per month. Conservatively the Company is projecting initial revenues from Japan of over $2 million dollars per year for 2018. ViaDerma President, D. Christopher Otiko will travel to Japan in January 2018 to meet with distributors and physicians who will be dispensing Vitastem to their patients.

Its marketing, sales and distribution partner, Biogenx, Inc. has been preselling the product, under the name of VitaStemtm. Which now retails for $79 and can be purchased online at www.Biogenx.net. The Company plans to start manufacturing the second production run of the product and now has streamlined the manufacturing.

The Company has signed an MOU and will start production of its Patent Pending CBD or Cannabinoids product line. The Company would combine its two Patent pending technologies, the MMJ Patent #62466209, a patent for delivering medical marijuana / cannabis to the body by applying the medication onto the skin in an ointment base topical solution and the second Provisional patent # 62433964 for enhanced antibiotic and drug delivery for "Aqueous Topical Applications" for human and veterinary uses. The Company would combine its proprietary solutions with CBD's and other natural products that treat psoriasis, fibromyalgia for pain and other ailments. The Company plans to continue to expand its (IP) "Intellectual Property Portfolio" in 2018.

ViaDerma President, Dr. Christopher Otiko, said, "Now that we have the manufacturing capabilities we are concentrating on ramping up sales and distribution and are seeing the orders come in from several countries. The response from our customers in all our testing trials have shown positive results and overwhelming interest in our products around the world. Our contract manufacturer has now streamlined the process and has the capabilities to manufacture most of our products. We are now manufacturing our new products and look forward to delivering several high-quality pharmaceuticals to our distributors."

About ViaDerma, Inc.
ViaDerma, Inc. (OTC PINK: VDRM) is a publicly traded specialty pharmaceutical company committed to bringing new products to market and licensing its innovative technology to current leaders in the pharmaceutical industry in a wide variety of therapeutic areas. ViaDerma's products use an innovative transdermal delivery method that allows for application of active ingredients in a topical form. This patent-pending dual carrier transdermal technology may be applied in products within the medical and cosmetic markets. Also, a patent application using the combination of CBD's and THC with the delivery system was filed in 2017. The use of CBD's is for the reduction of inflammation and for the treatment of several diseases, such as, nicotine addiction, fibromyalgia, Crohn's disease, schizophrenia, migraine headaches, pain management for cancer and Multiple Sclerosis. For more information, please visit: www.viadermalicensing.com

[SkeBallLarry]

( STEV ) wanting to move .. ??

[georgie18]

PURA...0414...

[gwat1979]

VDRM .014 moving

[CHIEF-RISES-ABOVE]

STSC .0009 about to go crazy, bottom is in before next leg

[Penny Machine]

CNXS 1mm to go till uptick